在抗脂综合征的精准医学方面
Chary Lopez-Pedrera1, Carlos Pérez-Sánchez2, Maria G Tektonidou3
1Rheumatology Service, Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain.
The Lancet. Rheumatology
|May 26, 2025
概括
精准医学通过分层患者来定制抗脂综合征 (APS) 的治疗方法. 了解遗传和分子差异可以提高治疗效率,并减少这种罕见的自身免疫性疾病的毒性.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
- 精准医学是一门精准的医学.
背景情况:
- 抗脂综合征 (APS) 是一种罕见的自身免疫性疾病,具有不同的临床表现和治疗结果.
- 患者异质性表明病理生理学和遗传学的潜在差异.
- 精准医学旨在解决这些变异,以提供量身定制的疗法.
研究的目的:
- 通过使用临床,遗传和生物分子数据,审查目前关于分层APS患者的证据.
- 探索人工智能在指导APS的精准医学中的作用.
主要方法:
- 对APS病理生理学,亚表型和欧米技术的现有文献的审查.
- 对临床,遗传,表观遗传和分子分析数据的分析.
- 在个性化APS治疗中对人工智能应用的评估.
主要成果:
- 欧米技术和微阵列分析的进步已经确定了关键的基因,表观遗传变异和生物标志物.
- 基于表型和分子形状的患者分层使得更有效的治疗定制成为可能.
- 人工智能算法在整合复杂数据以实现个性化治疗策略方面表现有前途.
结论:
- 抗脂综合征患者的分层对推进精准医学至关重要.
- 将临床,遗传和分子数据与人工智能集成,可以优化治疗效率并最大限度地降低毒性.
- 对患者亚表型和AI整合的进一步研究对于个性化的APS管理至关重要.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
36
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
36
Venous Thrombosis III: Interprofessional Care
29
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
29
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
48
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
48
Anticoagulant Drugs: Low-Molecular-Weight Heparins
934
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
934
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
656
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
656
Atherosclerosis III: Management
44
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
44


